Broadwood Pushes for Special Shareholder Meeting to Remove STAAR Surgical Directors
Broadwood Partners, holding a 30.2% stake in STAAR Surgical, is pushing for a Special Shareholder Meeting to remove three directors from STAAR's Board. They oppose the sale to Alcon Inc. and seek board changes to boost investor confidence and ensure an independent sale process. Broadwood warns against defensive tactics and calls for directors aligned with shareholder interests. More details at LetSTAARShine.com.
Broadwood Partners, the largest shareholder of STAAR Surgical Company with a 30.2% stake, is advancing efforts to call a Special Meeting of Shareholders to remove three directors from STAAR’s Board. Broadwood opposes the current agreement to sell STAAR to Alcon Inc. and argues that changes to the Board are necessary to restore investor confidence and ensure a more independent and effective sale process. The group urges STAAR’s Board to promptly hold the Special Meeting and warns against any defensive tactics, emphasizing the need for new directors who are better aligned with shareholder interests. Further information for shareholders is available at LetSTAARShine.com. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. STAAR Surgical Company published the original content used to generate this news brief via Business Wire (Ref. ID: 20251202015519) on December 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)
